Search - tctmd.com

Displaying 621 - 640 of 684

Sort: Relevancy | Date

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

FDA approves Repatha to treat certain patients with high cholesterol

August 28, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Industry News

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

August 20, 2015

News Industry News

Doctor's Best Introduces Two New Heart Health Supplements

August 11, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

News Industry News

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

July 23, 2015

News Industry News

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

July 21, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante

L.A. McKeown

June 29, 2015

News Industry News

FDA approves new antiplatelet drug used during heart procedure

June 24, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Industry News

China Interventional Cardiovascular Device Industry Report, 2014-2017

May 27, 2015

News Industry News

ORSIF Documentary Featuring Noted Heart Surgeon Dr. Edward Diethrich Tells Personal Story of Serious Health Risks from Occupational Exposure to Radiation in Fluoroscopy Labs

May 06, 2015

News Industry News

New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease

May 04, 2015

News Daily News

Recommendations Tackle Hypertension in CAD Patients

Todd Neale

April 03, 2015

News Daily News

Recomendaciones Abordan la Hipertensión en Pacientes EAC

Todd Neale

April 03, 2015

News Daily News

Meta-analysis: Mortality Lower With PCI vs Medical Therapy Alone in Stable Patients With Documented Ischemia

L.A. McKeown

March 24, 2015

News Industry News

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

February 24, 2015

Advertisement

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

FDA approves Repatha to treat certain patients with high cholesterol

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

Doctor's Best Introduces Two New Heart Health Supplements

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(a) Rx Published in The Lancet

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

Method Chosen to Estimate Pre-PCI Kidney Function Matters

El Método Elegido para Calcular la Función Renal Pre-PCI es Relevante

FDA approves new antiplatelet drug used during heart procedure

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

China Interventional Cardiovascular Device Industry Report, 2014-2017

ORSIF Documentary Featuring Noted Heart Surgeon Dr. Edward Diethrich Tells Personal Story of Serious Health Risks from Occupational Exposure to Radiation in Fluoroscopy Labs

New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease

Recommendations Tackle Hypertension in CAD Patients

Recomendaciones Abordan la Hipertensión en Pacientes EAC

Meta-analysis: Mortality Lower With PCI vs Medical Therapy Alone in Stable Patients With Documented Ischemia

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content